OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Emergence of SARS-CoV-2 with Dual-Drug Resistant Mutations During a Long-Term Infection in a Kidney Transplant Recipient
Yoko Tanino, Keisuke Nishioka, Chie Yamamoto, et al.
Infection and Drug Resistance (2024) Vol. Volume 17, pp. 531-541
Open Access | Times Cited: 7
Yoko Tanino, Keisuke Nishioka, Chie Yamamoto, et al.
Infection and Drug Resistance (2024) Vol. Volume 17, pp. 531-541
Open Access | Times Cited: 7
Showing 7 citing articles:
SARS-CoV-2 resistance to monoclonal antibodies and small-molecule drugs
Sho Iketani, David D. Ho
Cell chemical biology (2024) Vol. 31, Iss. 4, pp. 632-657
Open Access | Times Cited: 8
Sho Iketani, David D. Ho
Cell chemical biology (2024) Vol. 31, Iss. 4, pp. 632-657
Open Access | Times Cited: 8
Engineered DPP4 decoy confers broad-spectrum inhibition of MERS-CoV infection
Keisuke Nishioka, Yusuke Sakai, Daisuke Motooka, et al.
(2025), pp. 100018-100018
Open Access
Keisuke Nishioka, Yusuke Sakai, Daisuke Motooka, et al.
(2025), pp. 100018-100018
Open Access
Nirmatrelvir Resistance in an Immunocompromised Patient with Persistent Coronavirus Disease 2019
Chie Yamamoto, Masashi Taniguchi, Keitaro Furukawa, et al.
Viruses (2024) Vol. 16, Iss. 5, pp. 718-718
Open Access | Times Cited: 3
Chie Yamamoto, Masashi Taniguchi, Keitaro Furukawa, et al.
Viruses (2024) Vol. 16, Iss. 5, pp. 718-718
Open Access | Times Cited: 3
RNA Polymerase Inhibitor Enisamium for Treatment of Moderate COVID-19 Patients: A Randomized, Placebo-Controlled, Multicenter, Double-Blind Phase 3 Clinical Trial
Olga Holubovska, Pavlo Babich, Alla Mironenko, et al.
Advances in respiratory medicine (2024) Vol. 92, Iss. 3, pp. 202-217
Open Access | Times Cited: 1
Olga Holubovska, Pavlo Babich, Alla Mironenko, et al.
Advances in respiratory medicine (2024) Vol. 92, Iss. 3, pp. 202-217
Open Access | Times Cited: 1
Clinical validation of an RSV neutralization assay and analysis of cross-sectional sera associated with 2021–2023 RSV outbreaks to investigate the immunity debt hypothesis
Eli A. Piliper, Jonathan C. Reed, Alexander L. Greninger
Microbiology Spectrum (2024)
Closed Access | Times Cited: 1
Eli A. Piliper, Jonathan C. Reed, Alexander L. Greninger
Microbiology Spectrum (2024)
Closed Access | Times Cited: 1
Clinical validation of an RSV neutralization assay and testing of cross-sectional sera pre- and post- RSV outbreaks from 2021-2023
Eli A. Piliper, Jonathan C. Reed, Alexander L. Greninger
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Eli A. Piliper, Jonathan C. Reed, Alexander L. Greninger
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Enhanced Detection and Molecular Modeling of Adaptive Mutations in SARS-CoV-2 Coding and Non-Coding Regions Using the c/µ Test
Nicholas J. Paradis, Chun Wu
Virus Evolution (2024) Vol. 10, Iss. 1
Open Access
Nicholas J. Paradis, Chun Wu
Virus Evolution (2024) Vol. 10, Iss. 1
Open Access
